Day: April 30, 2024

GEMXX Corporation Announces New CEO and Strategic Expansion Plans

LAS VEGAS, April 30, 2024 (GLOBE NEWSWIRE) — via IBN – GEMXX Corporation ( OTC: GEMZ ) (“GEMXX” or the “Company”), a leading provider of exquisite gemstones and jewelry announces its plans to expand into proven business channels known to deliver substantial revenue and shareholder value, as well as a change in leadership. 1. Company Refocusing Plan: GEMXX has maintained stable revenues over the past year, despite global instability.  The company has been working hard to identify alternative revenue streams that will generate corporate growth and shareholder value. 2. Expansion and Innovation: GEMXX Corporation remains committed to expanding its horizons and exploring new growth opportunities. The company continues to identify new markets, strategic ventures and partnerships to drive revenue and shareholder...

Continue reading

AUGA group, AB has published Green Bond Report

In December 2019, AUGA group, AB issued and successfully distributed its first tranche of green bonds. The Company has an obligation to publish a separate annual report regarding the use of funds. This Green Bond Report (see attachment) provides an overview on the allocation of funds raised as of December 31, 2023. Contacts: Kristupas Baranauskas, AUGA group, AB CFOPhone: +370 652 99444Email: k.baranauskas@auga.lt Attachment Green bond report 2023

Continue reading

AUGA group, AB has published Consolidated Annual Report

AUGA group, AB (code 126264360, address Konstitucijos ave. 21C, Vilnius, Company) has published Company‘s Consolidated Annual Report, Consolidated and Separate Financial Statements and Independent Auditor‘s Report for the year ended 31 December 2023, also the Sustainability Report of the respective reporting period (hereto attached). The audited revenue for the year 2023 of AUGA group, AB and its subsidiaries (hereinafter – the Group) were EUR 77.44 million (EUR 81.41 million revenues were reported in interim financial statements for 12 months period ended 31 December 2023, hereinafter unaudited data). The Group‘s revenue was adjusted by eliminating revenue of the sold subsidiary Grybai LT for the whole year 2023. The audited net loss of the Group for year 2023 was EUR 18.45 million (unaudited net loss of EUR 17.96 million for year 2023...

Continue reading

NioBay Announces Closing of the First Tranche of a Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, April 30, 2024 (GLOBE NEWSWIRE) — NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce the closing of the first tranche of a private placement (the “Offering”). Under the Offering, the Company raised proceeds of $312,005 from the sale of 4,457,215 Quebec-eligible flow-through units of the Company (each, a “Québec FT Unit”) at a price of $0.07 per Quebec FT Unit. Each Québec FT Unit consists of one common share of the Company issued as a “flow-through share” within the meaning of the Income Tax Act (Canada) and the Taxation Act (Québec) and one half of one common share purchase warrant (each whole warrant, a “Warrant”). Each whole Warrant entitles the holder to purchase one Common...

Continue reading

Admiral Markets AS audited annual report 2023

Admirals witnesses a significant rise in active and new clients.  Number of new applications in the Group went up by 77% to 266,779 applications compared to 2022 and is up by 116% compared to 2021.  • Admiral Markets AS’ net trading income was EUR 9.1 million (2022: EUR 44.3 million, 2021: EUR 20.5 million and 2020: EUR 47.1 million) • EBITDA was EUR -6.9 million (2022: EUR 25.9 million, 2021: EUR 2.5 million and 2020: EUR 21.6 million) • Number of active clients in the Admirals Group went up by 62% to 89,764 clients compared to 2022 and is up by 83% compared to 2021 (2022: 55,242, 2021: 49,080 and 2020: 48,341 active clients). • Number of active accounts in the Group went up by 57% to 110,471 clients compared to 2022 and is up by 75% compared to 2021 (2022: 70,436, 2021: 63,231 and 2020: 62,854 active accounts). Statement...

Continue reading

Willis Lease Finance Corporation Closes on Third JOLCO Deal

COCONUT CREEK, Fla., April 30, 2024 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, announced today the closing of its third engine-backed Japanese operating lease with call option (“JOLCO”), a US$21 Million financing with a 5.0% interest loan maturing in March of 2033 on a CFM LEAP-1B28 engine. WLFC closed its first JOLCO engine transaction in August of 2023. “The JOLCO market is particularly attractive to us as we continue to modernize our portfolio and diversify our sources of capital,” said Scott B. Flaherty, the Company’s EVP and Chief Financial Officer. “The successful closing of our third engine JOLCO again demonstrates the Company’s access to the global capital markets, allowing us to...

Continue reading

BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately

Mr. Amato will also serve on the Company’s Board of Directors Westport, CT, April 30, 2024 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or “the Company”), a medical technology Company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced the appointment of Mr. Anthony Amato to the Position of Chief Executive Officer (“CEO”), effective immediately.  Additionally, Mr. Amato will serve on the Company’s Board of Directors, which is currently being assembled.  Recall, that on April 4, 2024, the Company announced the engagement of Consulting firm, Bridge Associates International Pharmaceutical Consulting (“BAIPC”), led by Mr. Amato.  This corporate action was the natural progression as the Company continues to realize meaningful progress towards...

Continue reading

Marie Brizard Wine & Spirits: Availability of the 2023 Universal Registration Document including the 2023 Annual Financial Report

                                                                Charenton-le-Pont, 30 April 2024 Availability of the 2023 Universal Registration Document including the 2023 Annual Financial Report Marie Brizard Wine & Spirits (Euronext: MBWS) announces that it has filed its Universal Registration Document for the year 2023 with the Autorité des Marchés Financiers (AMF) on 30 April 2024. This document includes, in particular, the following items: – the 2023 annual financial report, – the Board of Directors report on corporate governance, and – the auditors’ reports relating thereto. The Universal Registration Document is made available under the conditions stipulated by the prevailing regulations. It can be consulted on the MBWS website (http://www.mbws.com/) under the heading “Regulatory Information”...

Continue reading

Admirals Group AS audited annual report 2023

Admirals witnesses a significant rise in active and new clients. Number of new applications in the Group went up by 77% to 266,779 applications compared to 2022 and is up by 116% compared to 2021.  The Group net trading income was 40.9 million (2022: EUR 69.0 million, 2021: EUR 35.7 million and 2020: EUR 62.2 million). EBITDA was EUR -6.5 million (2022: EUR 27.4 million, 2021: EUR 2.6 million and 2020: EUR 23.4 million). Number of active accounts in the Group went up by 57% to 110,471 clients compared to 2022 and is up by 75% compared to 2021. Number of active clients in the Group went up by 62% to 89,764 clients compared to 2022 and is up by 83% compared to 2021. Statement of Financial Position     (in thousands of euros)   31.12.2022   31.12.2023   Assets     ...

Continue reading

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

CALGARY, Alberta, April 30, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its press release of March 11, 2024, the Company has received TSX Venture Exchange approval to amend the terms of an aggregate of 1,024,099 outstanding common share purchase warrants (“Warrants”) by amending the exercise price to USD $5.00 per share as follows: 198,333 of the Warrants were issued pursuant to Private Placement that closed on February 9, 2021. The Warrants had an original exercise price of CAD $42.26 per share ($0.40 adjusted to reflect consolidations that occurred on September 20, 2021 and November 10, 2023). The TSXV...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.